Meglitinide analogues: a review of clinical data focused on recent trials

Autor: JF Blicklé

Publikováno v: Diabetes & Metabolism. 32:113-120

Summary Glinides represent a chemically heterogeneous new class of insulinsecreting agents characterized by a rapid onset and short duration of action. They act by closure of the ATP-dependant K channel. Repaglinide, the only glinide available in Fra

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c93c24735acbc5817a77cd97b99b8b2
https://doi.org/10.1016/s1262-3636(07)70257-4

Les études de prévention médicamenteuse du diabète de type 2 doivent-elles nous amener à changer nos prescriptions?

Autor: JF Blicklé

Publikováno v: Diabetes & Metabolism. 29:547-553

Summary Should type 2 diabetes prevention pharmacological studies prompt us to change our prescription habits? Type 2 diabetes (T2D), a major public health problem in all parts of the world, is preceded by an identifiable phase of impaired glucose to

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::901b50cf8a8afb28a934a5995c086d52
https://doi.org/10.1016/s1262-3636(07)70070-8

Hematological response to short-term oral cyanocobalamin therapy for the treatment of cobalamin deficiencies in elderly patients

Autor: Andrès E, Kaltenbach G, Noblet-Dick M, Noel E, Vinzio S, Ae, Perrin, Berthel M, Jf, Blicklé

Publikováno v: Europe PubMed Central

The aim of this trial was to demonstrate the efficacy of one month of oral cobalamin (vitamin B12) therapy in elderly patients with cobalamin deficiency related to food-cobalamin malabsorption (FCM).Twenty elderly patients (mean age: 78+/-17 years) w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::53b32531a49d0cd9ae881fea05c18b97
https://pubmed.ncbi.nlm.nih.gov/16453051

Potential glycemic overtreatment in patients ≥75 years with type 2 diabetes mellitus and renal disease: experience from the observational OREDIA study.

Autor: Penfornis A; Department of Endocrinology and Diabetology, Centre Hospitalier Sud Francilien, Corbeil-Essonnes Cedex, France., Fiquet B; Clinical Affairs, Novartis Pharma SAS, Rueil-Malmaison, France., Blicklé JF; Department of Internal Medicine and Diabetology, Strasbourg University Hospital, Strasbourg, France., Dejager S; Clinical Affairs, Novartis Pharma SAS, Rueil-Malmaison, France ; Department of Diabetology, Metabolism and Endocrinology, Pitié-Salpétrière Hospital, Paris, France.

Publikováno v: Diabetes, metabolic syndrome and obesity : targets and therapy [Diabetes Metab Syndr Obes] 2015 Jul 03; Vol. 8, pp. 303-13. Date of Electronic Publication: 2015 Jul 03 (Print Publication: 2015).

Potential clinical impact of medication discrepancies at hospital admission.

Autor: Quélennec B; Pharmacy Department, University Hospital of Strasbourg, France., Beretz L, Paya D, Blicklé JF, Gourieux B, Andrès E, Michel B

Publikováno v: European journal of internal medicine [Eur J Intern Med] 2013 Sep; Vol. 24 (6), pp. 530-5. Date of Electronic Publication: 2013 Mar 18.